NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 6

Registration Number: NCT00000634

Locations: 🇺🇸
Univ of Massachusetts Med Ctr / Biotech II, Worcester, Massachusetts, United States

CMV Retinitis Retreatment Trial

Phase 2

Completed

Conditions: Cytomegalovirus Retinitis
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 300

Registration Number: NCT00000766

Locations: 🇺🇸
Johns Hopkins Hosp / SOCA, Baltimore, Maryland, United States
🇺🇸
New York Hosp - Cornell Med Ctr / Sloan - Kettering / SOCA, New York, New York, United States
🇺🇸
Mount Sinai Med Ctr / SOCA, New York, New York, United States

and more 6 locations

A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 200

Registration Number: NCT00001078

Locations: 🇺🇸
UCSF / Moffitt Hosp - Pediatric, San Francisco, California, United States
🇺🇸
Children's Hosp of Denver, Denver, Colorado, United States
🇺🇸
Phoenix Childrens Hosp, Phoenix, Arizona, United States

and more 47 locations

A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 35

Registration Number: NCT00001111

Locations: 🇺🇸
UCLA Med Ctr / Pediatrics, Los Angeles, California, United States
🇺🇸
Univ of Miami (Pediatric), Miami, Florida, United States
🇺🇸
Univ of Massachusetts Med Ctr / Biotech II, Worcester, Massachusetts, United States

and more 4 locations

An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 10

Registration Number: NCT00000747

Locations: 🇺🇸
UCSD, San Diego, California, United States

A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients

Phase 3

Completed

Conditions: Cytomegalovirus Infections
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-03-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 1200

Registration Number: NCT00001038

Locations: 🇨🇦
Montreal Chest Institute, Montreal, Quebec, Canada
🇨🇦
Southern Alberta HIV Clinic / Foothills Hosp, Calgary, Alberta, Canada
🇺🇸
Yale Univ, New Haven, Connecticut, United States

and more 32 locations

Changing to Nonprotease Inhibitor Treatment to Improve Side Effects

Phase 2

Completed

Conditions: HIV Infections
Lipodystrophy

First Posted Date: 2001-08-31

Last Posted Date: 2011-02-28

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 342

Registration Number: NCT00021463

Locations: 🇺🇸
Northwestern Univ Med School, Chicago, Illinois, United States
🇺🇸
Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Emory Univ, Atlanta, Georgia, United States

and more 8 locations

Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis

Phase 4

Completed

Conditions: Cytomegalovirus Retinitis
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-02-23

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 300

Registration Number: NCT00000894

Locations: 🇺🇸
Cornell Univ Med Ctr, New York, New York, United States
🇺🇸
Julio Arroyo, West Columbia, South Carolina, United States
🇺🇸
New York Hosp / Cornell Med Ctr, New York, New York, United States

and more 9 locations

The Effects of Prednisone on HIV Levels and the Immune System

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2011-02-23

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 118

Registration Number: NCT00000921

Locations: 🇺🇸
Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States
🇺🇸
Mount Sinai Med Ctr, New York, New York, United States
🇺🇸
Northwestern Univ Med School, Chicago, Illinois, United States

and more 15 locations

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Phase 3

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2012-05-21

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 1125

Registration Number: NCT00013520

Locations: 🇺🇸
The Ponce de Leon Ctr. CRS, Atlanta, Georgia, United States
🇺🇸
Northwestern University CRS, Chicago, Illinois, United States
🇺🇸
St. Louis ConnectCare, Infectious Diseases Clinic, St. Louis, Missouri, United States

and more 57 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy